BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference Biotech Investing
Orchard Therapeutics Scientific Advisory Board Member Presents Clinical Proof-of-Concept Data Biotech Investing
Naturally Splendid Appoints Compounding Pharmacist, Bob Mehr, to Advisory Board for NateraFX™ Cannabis Investing News
Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets Cannabis Investing News
Kalytera Announces Additional Share Issuance for Services under Payments Agreement with Salzman Group Cannabis Investing News
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA Therapeutics Platform Biotech Investing
